|
|
Toshiaki Kikuchi, Ronald G. Crystal
J Clin Invest. 2001;
108(6):917
doi:10.1172/JCI11564
Abstract |
Full text
| PDF

M
acrophage-derived chemokine (MDC) is a potent chemoattractant for antigen-specific T lymphocytes. We hypothesized that Adenovirus- (Ad-) transduced dendritic cells (DCs) overexpressing MDC would enhance the T cell–mediated humoral immune response specific for antigens presented by the DC. We challenged two strains of mice with lethal Pseudomonas aeruginosa infection 3 weeks after immunization with AdMDC-modified DCs pulsed with heat-killed P. aeruginosa. MDC-expressing DCs specifically attracted T lymphocytes and preserved typical DC surface phenotypes without growth factors in vitro. Mice immunized with AdMDC/Pseudomonas/DCs developed high levels of serum anti-Pseudomonas Ab’s and were protected from a lethal respiratory challenge with Pseudomonas. The in vivo protective immunity required CD4+ T cells, B cells, and IL-4, but not CD8+ T cells and IL-12. AdMDC/DCs pulsed with Pseudomonas yielded significant but not absolute cross-protection against different strains of P. aeruginosa. Pseudomonas-pulsed AdMDC/DCs protected mice from Pseudomonas but not Escherichia coli and vice versa; this microbe-specific protection correlated with microbe-specific induction of CD4+ T cell proliferation and IL-4 secretion. Based on these observations, AdMDC-modified DCs pulsed with a killed bacteria may be a useful approach to vaccination against infectious disorders.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(6)
| Title and authors |
Publication |
Year |
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.
Yuhuan Zheng, Zhen Cai, Siqing Wang, Xiang Zhang, Jianfei Qian, Sungyoul Hong, Haiyan Li, Michael Wang, Jing Yang, Qing Yi
|
Blood
|
2009 |
The immunity of splenic and peritoneal F4/80+ resident macrophages in mouse mixed allogeneic chimeras
Guangwei Liu, Haixia Ma, Lingling Jiang, Jianxia Peng, Yong Zhao
|
J Mol Med
|
2007 |
CC-chemokine ligand 17 gene therapy induces tumor regression through augmentation of tumor-infiltrating immune cells in a murine model of preexisting CT26 colon carcinoma
Naoko Kanagawa, Masakazu Niwa, Yutaka Hatanaka, Yoichi Tani, Shinsaku Nakagawa, Takuya Fujita, Akira Yamamoto, Naoki Okada
|
Int. J. Cancer
|
2007 |
Genetically Modified Dendritic Cells for Therapeutic Immunity
Toshiaki Kikuchi
|
Tohoku J. Exp. Med.
|
2006 |
Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors
Mio Nukiwa, Sita Andarini, Jamal Zaini, Hong Xin, Masahiko Kanehira, Takuji Suzuki, Tatsuro Fukuhara, Hiroyuki Mizuguchi, Takao Hayakawa, Yasuo Saijo, Toshihiro Nukiwa, Toshiaki Kikuchi
|
Eur. J. Immunol.
|
2006 |
Chemokines, their receptors, and transplant outcome1
Bridget L. Colvin, Angus W. Thomson
|
Transplantation
|
2002 |
|